Directors' Holdings

MemberShares
12/31/2018
Options
 12/31/2018
Prof. Dr. Horst Domdey, Chairman of Supervisory Board39,1250
Dr. Yita Lee00
Antoinette Hiebeler-Hasner00
Dr. Keith Manchester1)00
Ronald Scott 00
Dr. Gerd Zettlmeissl 00
Dr. Frank Mathias2)20,19746,0892)
Total Supervisory Board59,32246,089
Prof. Dr. Dolores J. Schendel, Chief Executive Officer and Chief Scientific Officer 3)846,29672,500
Dr. Kai Pinkernell, Chief Medical Officer and Chief Development Officer (since 4/1/2018)050,938
Dr. Thomas Taapken, CFO (until 8/31/2018)n.a.n.a.
Total Executive Board846,296123,438

1) Dr. Manchester is Managing Director and Head at Life Sciences QVT Financial LP. Funds managed by QVT held 1,072,879 shares in Medigene AG according to the last voting rights notification as of 08 June 2018.

2) The stated number of options corresponds to 124,839 options prior to a capital reduction in 2013.

3) Prof. Dr. Schendel indirectly holds 846,296 Medigene shares in her capacity as Managing Director of DJS Montana Holding GmbH, which all are directly allocated to Prof. Dr. Schendel.